Endo International | Der Umsatz



Der Umsatz Veränderung Datum
AbbVie USD 16.62B 840M 2025-12
Amarin USD 49.67M 23.07M 2025-09
ANI Pharmaceuticals USD 227.81M 16.44M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 7.6M 46.54M 2025-03
Eli Lilly USD 19.3B 1.7B 2025-12
Heron Therapeutics USD 32.81M 3.21M 2024-09
Hikma Pharmaceutical USD 829M 758M 2025-06
Ligand Pharmaceuticals USD 115.46M 67.83M 2025-09
Merck USD 16.4B 880M 2025-12
Novartis USD 13.91B 144M 2025-09
Pacira USD 179.52M 1.58M 2025-09
Perrigo USD 1.04B 16.3M 2025-09
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 309.26M 48.83M 2024-12
Supernus Pharmaceuticals USD 192.1M 26.6M 2025-09
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xeris Pharmaceuticals USD 74.38M 2.84M 2025-09
Zoetis USD 2.4B 0 2025-12


Endo International Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.